Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 03, 2021
IQVIA, a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, is launching new Research Nursing and Phlebotomy services. These new services offer patients participating in clinical trials...
read more
Thursday, February 20, 2020
IQVIA has announced the launch of Avacare Clinical Research Network, a technology-based global site network that opens opportunities for trials at clinical and research sites.
read more
Wednesday, August 21, 2019
IQVIA™ has announced the launch of the IQVIA Patient Portal, a global web-based solution built on a leading health cloud platform. This innovative tool enables increases in clinical trial patient recruitment, engagement and retention by ensuring ...
read more
Isarna Therapeutics GmbH announced today that it
has signed a strategic manufacturing agreement with Sanofi under which Sanofi will
manufacture clinical- and commercial-grade antisense oligonucleotide (ASO) compounds for
Isarna, enabling Isarna to...
read more
ISPE, the International Society for Pharmaceutical Engineering, announced today it is currently conducting a global survey on patient experiences with clinical trial materials. The survey is designed to obtain feedback on areas such as the ...
read more
Thursday, December 11, 2014
Camargo Pharmaceutical Services, a leading drug development organization specializing in the 505(b)(2) approval pathway, joined inPack to present a seminar, “Non-Clinical and Clinical Study Design Factors in a Clinical Trial Protocol,” on Dec. 9 in ...
read more
Iterative Scopes, a provider of precision medicine technologies for gastroenterology, has acquired Clinical Research Strategy Group, LLC and Precision Research (CRSG/Precision),
read more
Wednesday, April 17, 2013
JHP Pharmaceuticals, a leading provider of global contract manufacturing services for sterile products has entered into an agreement with an undisclosed biotechnology company to produce clinical supplies of a biologic for late-phase clinical trials.
read more
The Investigational New Drug (IND) relates to a novel molecule targeting prostate cancer which will now progress towards the next stage of development, with clinical trials expected next year
read more
Kayentis announces it is moving ahead on five new eCOA service projects with Emerging BioPharma (EBP) companies.
read more
Wednesday, March 23, 2022
Kayentis has announced the launch of a fully integrated patient-centric platform that optimizes the management of hybrid and Decentralized Clinical Trials (DCT).
read more
Samsung Biologics signed a strategic partnership agreement with Kineta, Inc., a clinical-stage biotech company developing novel immunotherapies in oncology. Samsung Biologics will provide end-to-end CDMO service from cell line development, clinical ...
read more
Kodiak Sciences Inc. and Lonza announced the opening of a new, custom-built, bioconjugation facility within Lonza’s Ibex® Dedicate manufacturing complex in Visp (CH).
read more
Medidata, a Dassault Systèmes company, announced that Labcorp has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of...
read more
Friday, November 14, 2014
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) and Covance Inc. (NYSE: CVD) today announced that they have entered into a definitive agreement under which LabCorp will acquire Covance for cash and LabCorp shares currently valued at...
read more